Bellanne-Chantelot C, Clauin S, Chauveau D et al (2005) Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 54:3126–3132

Article  CAS  PubMed  Google Scholar 

Bowman P, Flanagan SE, Edghill EL et al (2012) Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia 55:123–127

Article  CAS  PubMed  Google Scholar 

Cherif Titah SM, Meunier I, Blanchet C et al (2012) Cataract as a phenotypic marker for a mutation in WFS1, the Wolfram syndrome gene. Eur J Ophthalmol 22:254–258

Article  Google Scholar 

Colarusso JL, Zhou Q (2022) Direct reprogramming of different cell lineages into pancreatic β-like cells. Cell Reprogram 24:252–258

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edghill EL, Stals K, Oram RA et al (2013) HNF1B deletions in patients with young-onset diabetes but no known renal disease. Diabet Med 30:114–117

Article  CAS  PubMed  Google Scholar 

Giuffrida FM, Reis AF (2005) Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes Metab 7:318–326

Article  CAS  PubMed  Google Scholar 

Hattersley AT, Greeley SAW, Polak M et al (2018) ISPAD clinical practice consensus guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 19:47–63

Article  PubMed  Google Scholar 

Lim HD, Lee SM, Yun YJ et al (2023) WFS1 autosomal dominant variants linked with hearing loss: update on structural analysis and cochlear implant outcome. BMC Med Genomics 16:79

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maxwell KN et al (2016) Evaluation of ACMG-guideline-based variant classification of cancer susceptibility and non-cancer associated genes in families affected by breast cancer. Am J Hum Genet 98:801–817

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melloul D, Tsur A, Zangen D (2002) Pancreatic duodenal homeobox (PDX-1) in health and disease. J Pediatr Endocrinol Metab 5:1461–1472

Google Scholar 

Nakhleh A, Goldenberg-Furmanov M, Goldstein R et al (2023) A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12). J Diabetes Complications 37:108566

Article  CAS  PubMed  Google Scholar 

Njølstad PR, Søvik O, Cuesta-Muñoz A et al (2001) Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588–1592

Article  PubMed  Google Scholar 

Nowak N, Hohendorff J, Solecka I et al (2015) Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus. Endocrine 50:643–649

Article  CAS  PubMed  PubMed Central  Google Scholar 

Osbak KK, Colclough K, Saint-Martin C et al (2009) Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 30:1512–1526

Article  CAS  PubMed  Google Scholar 

Pearson ER, Pruhova S, Tack CJ et al (2005) Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia 48:878–885

Article  CAS  PubMed  Google Scholar 

Pearson ER, Boj SF, Steele AM et al (2007) Macrosomia and hyperinsulinemic hypoglycemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 4:e118

Article  PubMed  PubMed Central  Google Scholar 

Peixoto-Barbosa R, Reis AF, Giuffrida FMA (2020) Update on clinical screening of maturity-onset diabetes of the young (MODY). Diabetol Metab Syndr 12:1–14

Article  Google Scholar 

Ræder H, Haldorsen IS, Ersland L et al (2007) Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes 56:444–449

Article  PubMed  Google Scholar 

Ræder H, McAllister FE, Tjora E et al (2014) Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid. Diabetes 63:259–269

Article  PubMed  Google Scholar 

Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–423

Article  PubMed  PubMed Central  Google Scholar 

Roncero I, Alvarez E, Chowen JA et al (2004) Expression of glucose transporter isoform GLUT-2 and glucokinase genes in human brain. J Neurochem 88:1203–1210

Article  CAS  PubMed  Google Scholar 

Shepherd M, Shields B, Hammersley S et al (2016) Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the UK pediatric diabetes population with monogenic diabetes. Diabetes Care 39:1879–1888

Article  CAS  PubMed  Google Scholar 

Stenson PD, Mort M, Ball EV et al (2009) The human gene mutation database: 2008 update. Genome Med 1:1–6

Article  Google Scholar 

Stride A, Vaxillaire M, Tuomi T et al (2002) The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45:427–435

Article  CAS  PubMed  Google Scholar 

Valkovicova T, Skopkova M, Stanik J et al (2019) Novel insights into genetics and clinics of the HNF1A-MODY. Endocr Regul 53:110–134

Article  PubMed  Google Scholar 

Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), ncbi.nlm.nih.gov/clinvar/submitters/505954/

Ensembl VEP pick options. https://www.ensembl.org/info/docs/tools/vep/script/vep_other.html#pick_options. Accessed 28 June 2024

ClinGen RASopathy Expert Panel (ClINGEN-RAS), ncbi.nlm.nih.gov/clinvar/submitters/506439/

Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA), ncbi.nlm.nih.gov/clinvar/submitters/504863/

Pharmacogenomics Knowledge Base, Stanford University (PharmGKB), ncbi.nlm.nih.gov/clinvar/submitters/500295/

The Clinical and Functional TRanslation of CFTR (CFTR2), ncbi.nlm.nih.gov/clinvar/submitters/500092/